Literature DB >> 25480427

Complete clinical and biochemical control with cabergoline and octreotide in a patient with ectopic ACTH syndrome before surgery.

R Modica1, A Colao1, A Faggiano2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25480427     DOI： 10.1007/s40618-014-0221-3

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  3 in total

1.  The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up.

Authors:  Andrea M Isidori; Gregory A Kaltsas; Carlotta Pozza; Vanni Frajese; John Newell-Price; Rodney H Reznek; Paul J Jenkins; John P Monson; Ashley B Grossman; G Michael Besser
Journal:  J Clin Endocrinol Metab       Date:  2005-11-22       Impact factor: 5.958

2.  Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health.

Authors:  Ioannis Ilias; David J Torpy; Karel Pacak; Nancy Mullen; Robert A Wesley; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2005-05-24       Impact factor: 5.958

Review 3.  Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome.

Authors:  C de Bruin; R A Feelders; S W J Lamberts; L J Hofland
Journal:  Rev Endocr Metab Disord       Date:  2008-07-19       Impact factor: 6.514
  3 in total
  1 in total

Review 1.  The dopaminergic control of Cushing's syndrome.

Authors:  R Pivonello; C Pivonello; C Simeoli; M C De Martino; A Colao
Journal:  J Endocrinol Invest       Date:  2022-04-23       Impact factor: 5.467
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.